PEOPLE - MediSpectra makes appointment:
This article was originally published in Clinica
MediSpectra has appointed Dr James Myrtle as vice-president of clinical affairs. Prior to joining the US developer of non-contact optical biopsy systems, Dr Myrtle had held various positions in Chiron Diagnostics, Boehringer Mannheim, and SmithKline Clinical Labs.
You may also be interested in...
The latest drug development news and highlights from the Pink Sheet’s US FDA Performance Tracker.
US FDA’s latest effort to provide guidance for consumers on pharmacogenomics tests underscores the challenges the agency faces in the absence of a clear regulatory framework for lab-developed tests – and with no easy mechanism to update labels for off-patent drugs.